-
1
-
-
84858964598
-
Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy: The extended JAPAN-ACS study
-
Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, et al. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy: The extended JAPAN-ACS study. Circ J 2012; 76: 825-832.
-
(2012)
Circ J
, vol.76
, pp. 825-832
-
-
Miyauchi, K.1
Daida, H.2
Morimoto, T.3
Hiro, T.4
Kimura, T.5
Nakagawa, Y.6
-
2
-
-
84861594738
-
Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization: Perspectives from the CREDO-Kyoto registry cohort-2
-
Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, et al. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization: Perspectives from the CREDO-Kyoto registry cohort-2. Circ J 2012; 76: 1369-1379.
-
(2012)
Circ J
, vol.76
, pp. 1369-1379
-
-
Natsuaki, M.1
Furukawa, Y.2
Morimoto, T.3
Nakagawa, Y.4
Ono, K.5
Kaburagi, S.6
-
3
-
-
0037840242
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial
-
Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016.
-
(2003)
Lancet
, vol.361
, pp. 2005-2016
-
-
Collins, R.1
Armitage, J.2
Parish, S.3
Sleigh, P.4
Peto, R.5
-
4
-
-
4344683381
-
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
-
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
-
(2004)
Lancet
, vol.364
, pp. 685-696
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
Hitman, G.A.4
Neil, H.A.5
Livingstone, S.J.6
-
5
-
-
33746431474
-
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)
-
Knopp RH, d’Emden M, Smilde JG, Pocock SJ. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care 2006; 29: 1478-1485.
-
(2006)
Diabetes Care
, vol.29
, pp. 1478-1485
-
-
Knopp, R.H.1
D’emden, M.2
Smilde, J.G.3
Pocock, S.J.4
-
6
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto, A.M.5
Kastelein, J.J.6
-
7
-
-
84878773567
-
Risk of incident diabetes among patients treated with statins: Population based study
-
Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM. Risk of incident diabetes among patients treated with statins: Population based study. BMJ 2013; 346: 2610.
-
(2013)
BMJ
, vol.346
, pp. 2610
-
-
Carter, A.A.1
Gomes, T.2
Camacho, X.3
Juurlink, D.N.4
Shah, B.R.5
Mamdani, M.M.6
-
8
-
-
79959428660
-
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis
-
Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: A meta-analysis. JAMA 2011; 305: 2556-2564.
-
(2011)
JAMA
, vol.305
, pp. 2556-2564
-
-
Preiss, D.1
Seshasai, S.R.2
Welsh, P.3
Murphy, S.A.4
Ho, J.E.5
Waters, D.D.6
-
9
-
-
77549087054
-
Statins and risk of incident diabetes: A collaborative metaanalysis of randomised statin trials
-
Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: A collaborative metaanalysis of randomised statin trials. Lancet 2010; 375: 735-742.
-
(2010)
Lancet
, vol.375
, pp. 735-742
-
-
Sattar, N.1
Preiss, D.2
Murray, H.M.3
Welsh, P.4
Buckley, B.M.5
De Craen, A.J.6
-
10
-
-
84901704225
-
Higher potency statins and the risk of new diabetes: Multicentre, observational study of administrative databases
-
Dormuth CR, Filion KB, Paterson JM, James MT, Teare GF, Raymond CB, et al. Higher potency statins and the risk of new diabetes: Multicentre, observational study of administrative databases. BMJ 2014; 348: 3244.
-
(2014)
BMJ
, vol.348
, pp. 3244
-
-
Dormuth, C.R.1
Filion, K.B.2
Paterson, J.M.3
James, M.T.4
Teare, G.F.5
Raymond, C.B.6
-
11
-
-
84864861863
-
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial
-
Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial. Lancet 2012; 380: 565-571.
-
(2012)
Lancet
, vol.380
, pp. 565-571
-
-
Ridker, P.M.1
Pradhan, A.2
Macfadyen, J.G.3
Libby, P.4
Glynn, R.J.5
-
12
-
-
84897970506
-
ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(Suppl 2): S1-S45.
-
(2013)
Circulation 2014; 129(Suppl
, vol.2
, pp. S1-S45
-
-
Stone, N.J.1
Robinson, J.G.2
Lichtenstein, A.H.3
Bairey Merz, C.N.4
Blum, C.B.5
Eckel, R.H.6
-
13
-
-
33846414720
-
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
-
Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88-136.
-
(2007)
Eur Heart J
, vol.28
, pp. 88-136
-
-
Rydén, L.1
Standl, E.2
Bartnik, M.3
Van Den Berghe, G.4
Betteridge, J.5
De Boer, M.J.6
-
14
-
-
44349104255
-
Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes
-
Takaguri A, Satoh K, Itagaki M, Tokumitsu Y, Ichihara K. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes. J Pharmacol Sci 2008; 107: 80-89.
-
(2008)
J Pharmacol Sci
, vol.107
, pp. 80-89
-
-
Takaguri, A.1
Satoh, K.2
Itagaki, M.3
Tokumitsu, Y.4
Ichihara, K.5
-
15
-
-
34548476976
-
Usefulness of hydrophilic vs lipophilic statins after acute myocardial infarction: Subanalysis of MUSASHI-AMI
-
Sakamoto T, Kojima S, Ogawa H, Shimomura H, Kimura K, Ogata Y, et al. Usefulness of hydrophilic vs lipophilic statins after acute myocardial infarction: Subanalysis of MUSASHI-AMI. Circ J 2007; 71: 1348-1353.
-
(2007)
Circ J
, vol.71
, pp. 1348-1353
-
-
Sakamoto, T.1
Kojima, S.2
Ogawa, H.3
Shimomura, H.4
Kimura, K.5
Ogata, Y.6
|